Profile of:

Gavin Clunie

Consultant Rheumatologist and Metabolic Bone Disease at Cambridge University Hospitals in UK.

Full name: Gavin Clunie

Current country: United Kingdom

Membership level: Full

Type of membership: Member

Number of publications: 6

Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features? (2020)

Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis (2018)

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial (2015)

An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis (2014)

Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study (2014)

‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass (2012)